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Abstract
The regenerative potential diminishes with age and this has been ascribed to functional impairments of adult stem cells.
Cells in culture undergo senescence after a certain number of cell divisions whereby the cells enlarge and finally stop
proliferation. This observation of replicative senescence has been extrapolated to somatic stem cells in vivo and might
reflect the aging process of the whole organism. In this study we have analyzed the effect of aging on gene expression
profiles of human mesenchymal stromal cells (MSC) and human hematopoietic progenitor cells (HPC). MSC were isolated
from bone marrow of donors between 21 and 92 years old. 67 genes were age-induced and 60 were age-repressed. HPC
were isolated from cord blood or from mobilized peripheral blood of donors between 27 and 73 years and 432 genes were
age-induced and 495 were age-repressed. The overlap of age-associated differential gene expression in HPC and MSC was
moderate. However, it was striking that several age-related gene expression changes in both MSC and HPC were also
differentially expressed upon replicative senescence of MSC in vitro. Especially genes involved in genomic integrity and
regulation of transcription were age-repressed. Although telomerase activity and telomere length varied in HPC particularly
from older donors, an age-dependent decline was not significant arguing against telomere exhaustion as being causal for
the aging phenotype. These studies have demonstrated that aging causes gene expression changes in human MSC and HPC
that vary between the two different cell types. Changes upon aging of MSC and HPC are related to those of replicative
senescence of MSC in vitro and this indicates that our stem and progenitor cells undergo a similar process also in vivo.
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Introduction
The regenerative potential of our body decreases upon aging.
Regenerative tissues depend on specialized adult stem cells, thus
aging in these tissues can be interpreted as signs of aging in somatic
stem cells [1]. Adult stem cells are characterized by the dual
function to differentiate into different cell lineages and to self-
renew for maintenance of the stem cell pool. It is, however, still
controversial if this self-renewal also includes juvenation or if adult
stem cells are doomed to undergo aging upon each cell division. It
is unclear if adult stem cells undergo functional and molecular
changes, if their number decreases because of aging, or if aging is
due to extrinsic environmental factors without any effect on the
stem cell pool [2,3].
Research on adult stem cells is limited by the available methods
for their identification and purification. Hematopoietic stem cells
(HSC) represent the so far best described type of adult stem cells.
They give rise to all different blood cell lineages and have been
used for more than 40 years in clinical therapy. Nevertheless, it is
still not possible to isolate a homogeneous population of long-term
reconstituting HSC or to expand these cells in vitro. However, they
can be enriched within the subset of CD34
+ hematopoietic
progenitor cells (HPC).
Mesenchymal stromal cells (MSC) represent another multipo-
tent cell population that, given the appropriate culture conditions,
is able to differentiate into different mesodermal cell lineages
including osteocytes, chondrocytes and adipocytes. In the
literature they are commonly termed ‘‘mesenchymal stem cells’’
but also here reliable markers for the sub-fraction that meets the
specific stem cell criteria are yet elusive and therefore they should
rather be named ‘‘mesenchymal stromal cells’’ [4]. MSC are
predominantly isolated by plastic adherent growth under specific
culture conditions and therefore they are notoriously heteroge-
neous [5,6]. Nevertheless, human MSC raise hope in regenerative
medicine and their use is concurrently tested in a fast growing
number of clinical trials (www.clinicaltrials.gov) [7].
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of cell divisions [8]. Within about 20 to 50 population doublings,
cells enlarge, become more granular, and slow down their
proliferation rate. Ultimately they irrevocably stop cell division
although they remain metabolically active and can be maintained
in this state for years. This phenomenon of replicative senescence
was already described over forty years ago by Leonard Hayflick
[9,10] and since then, it is debated if the so-called ‘‘Hayflick limit’’
reflects the aging process of the whole organism in vivo. All human
somatic cells that can be grown successfully in culture undergo
cellular senescence in vitro [11]. For MSC research this is of specific
interest as various studies demonstrated functional implications of
their differentiation potential by long-term culture [12–16].
We have previously demonstrated that replicative senescence of
MSC is a continuous process starting at the first cell passage [16].
Various genes were differentially expressed and these changes
were very consistent in different donor samples. In continuation of
this research we have now compared primary human MSC and
HPC derived from donors of different age groups. The aim of this
study was to determine the molecular sequel of aging in human
stem and progenitor cells and to analyze if there is a molecular
relationship between aging and replicative senescence.
Results
MSC from young and elderly donors
In this study, we have isolated human MSC of young donors
(21–25 years), median aged donors (44–55 years) and elderly
donors (80–92 years; four donors per group). Plastic adherent
colonies were observed in all donor samples after 7 to 10 days. Cell
preparations fulfilled the criteria for definition of MSC [17]: 1)
typical plastic adherent growth, 2) expression of CD13, CD29,
CD44, CD73, CD90, CD105, CD146 and CD166 and absence of
the surface molecules CD31, CD34 and CD45 (figure S1), and 3)
in vitro differentiation potential towards osteogenic and adipogenic
lineage (figure S2). We did not observe any difference in MSC of
young and elderly donors with regard to growth morphology,
immunophenotype and differentiation potential although there
was some variation between different donor samples. Upon serial
passaging, the cells underwent replicative senescence. This is
reflected by the expression of senescence associated beta-
galactosidase (SA-beta-gal; figure S3) and it was accompanied by
decreased adipogenic differentiation potential and increased
osteogenic potential as described before [16]. The proliferation
rate decreased gradually until the cells finally stopped proliferation
after 50 to 90 days (figure 1). The cumulative number of
population doublings (PD) varied between 7 and 22 plus an
estimated 7 to 9 population doublings during the initial colony
formation. Thus, the total number of cumulative population
doublings would be between 14 and 31 corresponding to a 10
4-
fold to 10
9-fold expansion as also described by others [12,18–20].
Long-term growth curves differed considerably between the
different donor samples but there was no clear association between
the maximal number of PD and donor age.
Age-induced gene expression changes in MSC
MSC from different-aged donors were harvested after the
second passage to determine age-induced changes in their gene
expression profiles. 99 expressed sequence tags (ESTs; including
67 non-redundant genes) were significantly up-regulated with
increasing donor age whereas 85 ESTs (including 60 non-
redundant genes) were significantly down-regulated (table S1,
figure 2). Among the up-regulated genes were: mesenchyme
homeobox 2 (MEOX2) that functions as a negative regulator of
proliferation in several mesodermal tissues and that is most
affected in fibroblasts of patients with Hutchinson-Gilford progeria
syndrome [21]; short stature homeobox 2 (SHOX2) that is
thought to be responsible for idiopathic short stature [22]; and
HOXC6, which is part of a developmental regulatory system. On
the other hand, various homeobox genes were age-repressed
including HOXA5, HOXB3, HOXB7 as well as the paired-like
homeodomain transcription factor 2 (PITX2).
To validate microarray data by independent means, we have
performed quantitative RT-PCR. Five up-regulated and five
down-regulated genes were selected for differential gene expres-
sion analysis upon aging of MSC. The results for the 12 MSC
samples used for microarray analysis were in line with the
microarray data demonstrating the reliability of the method
(figure 3A). Furthermore, we have studied MSC from two young
(26 and 29 years), two median aged (35 and 45 years) and two
elderly (76 and 85 years) donors. Overall, age-associated
differential gene expression could be verified for all genes tested
(figure S4A).
Aging of MSC in vivo correlates with senescence in vitro
We have previously demonstrated that replicative senescence of
MSC is associated with continuous changes in their gene
expression profiles [16]. For a direct comparison with age-induced
gene expresssion changes we have reanalyzed the data of 9
different passages of the same donor (BM, 44 years old) by using
the same statistical methods. 1257 ESTs (including 721 non-
redundant genes) were significantly up-regulated in higher
passages, whereas 698 (including 481 non-redundant genes) were
down-regulated (figure S5; table S2). Subsequently, we have
compared age-induced differential gene expression and replicative
senescence associated gene expression changes. The color coded
presentation of profiles revealed that many gene expression
changes upon aging are also differentially expressed upon serial
passaging in vitro (figure 2). Alternatively we have compared
replicative senescence of different donor samples using the
statistical methods as described in our previous work and again
there was a correlation with differential expression upon aging.
Thus, long-term culture of MSC induced continuous changes in
the global gene expression profile and these changes were related
to differential gene expression of MSC from different donor age.
Gene expression changes in HPC upon aging
Furthermore, we have isolated the CD34
+ fraction of hemato-
poietic progenitor cells of different-aged donors to determine the
impact of aging on their gene expression profiles. HPC were
isolated from 4 cord blood samples and from mobilized peripheral
blood of 15 healthy donors between 27 and 73 years. There was
no correlation between the number of mono-nucleated cells
(MNC), the number of CD34
+ cells or, the percentage of CD34
+
cells with regard to donor age, suggesting that the number of
mobilized HPC does not vary significantly upon aging (figure S6).
Gene expression analysis revealed that 776 ESTs (including 432
non-redundant genes) were significantly up-regulated with in-
creasing donor age whereas 704 ESTs (including 495 non-
redundant genes) were down-regulated (table S3). Among the age-
induced genes were: laminin A (LMNA) that is mutated in
Hutchinson-Gilford progeria [21,23]; the glycoprotein clusterin
(CLU) that plays a role in apoptotic cell death and aggregates
within plaques in the brains of Alzheimer’s patients; CD44;
annexins ANXA1, ANXA2 and ANXA3; the homeobox genes
HOXA7, HOXB5, HOXB6 and HOXB7; and a remarkable
over-representation of genes involved in major histocompatibility
complexes (HLA-A, HLA-B, HLA-C, HLA-DRB1, HLA-DRB3,
Aging of Human Stem Cells
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aging of murine leukocytes [24,25]. In contrast, we did not observe
an effect of aging on the expression of the CD34 gene in HPC.
To validate the microarray data we have selected six up-
regulated and five down-regulated genes for RT-PCR analysis
(figure 3B) and the results were further verified for eight
independent samples (figure S4B).
Aging of HPC in vivo correlates with replicative
senescence of MSC
Just as any somatic cell, also HPC can only be cultured in vitro
for a limited number of cell divisions. Reliable methods for
selective expansion of HPC are yet elusive and the progeny results
predominantly in more differentiated cell types. This is reflected
by the rapid decline of CD34 expression after only a few cell
divisions [26]. Therefore, gene expression changes upon long-term
culture of HPC might rather be due to differentiation than to
replicative senescence. Instead, we have compared age-induced
gene expression changes in HPC with the previously described
dataset on replicative senescence in MSC. Color coding in the heat
map demonstrated that age-induced gene expression changes in
HPC were related to gene expression changes upon replicative
senescence of MSC in vitro (figure 4).
Age associated gene expression changes vary in different
cell types
The three datasets (MSC-donor age; MSC-replicative senescence and
HPC-donor age; (figure 5) were then collectively analyzed. Overall,
there was little overlap and only the small nuclear RNA activating
complex 5 (SNAPC5) was consistently down-regulated upon aging
in MSC and HPC as well as during replicative senescence of MSC
[27]. Notably, age-induced gene expression in MSC and HPC
showed only moderate overlap indicating that age-associated
changes differ considerably between different cell types. However,
there was a significant concordance of genes that were regulated
upon aging of MSC and upon replicative senescence of MSC
(P=0.003). Other genes also revealed a concordance between
aging of HPC and replicative senescence of MSC (P=4.5610
28).
Thus, aging of human stem and progenitor cells in vivo and cellular
senescence in vitro seems to be related to a comparable molecular
basis.
Differential gene expression was further analyzed with regard to
Gene Ontology (GO) categories. Several functional categories
were significantly over-represented in each of the three datasets
within either age-induced or age-repressed genes (figure S7).
Similar functional categories were age repressed: GO categories
related to the DNA repair, mitosis, transcriptional regulation and
nucleus were age-repressed in MSC, HPC as well as in replicative
senescence of MSC. In contrast, genes involved in categories for
differentiation, plasma membrane and extracellular matrix were
age-induced in MSC, HPC and replicative senescence.
Chromatin remodeling or confined epigenetic modifications
might result in chromosomal hot-spots for age-induced gene
expression changes. To test this hypothesis we have checked the
representation of the differentially expressed genes within
chromosomal regions (G-banding). Indeed, there were significant
over-representations at specific chromosomal sites (table S4).
However, these hot-spots did not coincide in up- and down-
regulated genes of all three datasets (MSC-donor age; MSC-replicative
senescence and HPC-donor age). This indicates that the underlying
mechanism of aging and replicative senescence of adult stem cells
is not attributed to regulation of gene expression at specific
chromosomal locations.
Analysis of telomerase activity and telomere length in
HPC upon aging
Although it is supposed that HSC are telomerase-positive and
thus should maintain a stable telomere length [28], there is
Figure 1. Long-term growth curves of mesenchymal stromal cells (MSC). Cells were isolated from human bone marrow from the iliac crest
(BM) or from the femoral head (HIP) of donors that were either young (21–25 years), median aged (44–55 years) or old (80–92 years). Cell numbers
were determined at the end of every passage and cumulative population doublings (PD) were calculated in relation to the cell numbers at the first
passage.
doi:10.1371/journal.pone.0005846.g001
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shortening can limit the maintenance and function of adult stem
cells [29]. Thus, age-dependent telomere shortening may be
causally associated with the age-dependent changes described
above. To address this we additionally investigated the CD34
+
HPC for their telomerase activity and telomere lengths. Using the
TRAP (telomere repeat amplification protocol) assay to measure
telomerase activity, we found all 13 HPC samples to be
telomerase-positive. Also in line with previous reports, the activity
varied from very weak levels to levels comparable to that seen in
the immortal HaCaT skin keratinocytes, i.e. a level sufficient to
maintain stable telomere length during serial passaging (figure 6)
[30,31]. Because of this variation, which was further confirmed by
serial dilution analysis of all samples in order to avoid false
negative (inhibitors) or positive (primer dimers) results (figure S8),
an age-dependent decline was not obvious.
In addition, we also determined telomere length from all 19
HSC populations. Due to the low number of cells available from
each isolation, we performed 3D Telo-FISF analysis, allowing for
quantitation of telomere length of each individual cell [30]. This
study showed an only weak tendency of age-dependent telomere
shortening and no sign of subpopulations with increased
telomere attrition. With the exception of one sample (mostly
two apoptotic cells) we also did not detect up-regulation of p53
or the formation of p53BP1-positive damage foci thus excluding
uncapped telomeres in the HSC populations including those
from the oldest donors (figure 6). However, there was a tendency
for an increasing interpersonal heterogeneity of telomere length
with age. Since this heterogeneity did not simply reflect the
respective level of telomerase activity these data may argue for a
more complex regulation of telomerase and telomere length in
HSC.
Figure 2. Age-induced gene expression in MSC is similar to replicative senescence. Global gene expression profiles of 12 MSC samples of
different donor age were analyzed by Affymetrix technology. Statistical analysis by template matching (PTM) revealed that 99 ESTs were significantly
up-regulated (red) and 85 ESTs were down-regulated (green) with increasing donor age. These differentially expressed genes were further analyzed
within the dataset of nine different passages of the same MSC donor sample (44 years old). Colour coding in the heat map demonstrates that gene
expression changes upon aging are also reflected by replicative senescence of MSC in vitro.
doi:10.1371/journal.pone.0005846.g002
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PLoS ONE | www.plosone.org 4 June 2009 | Volume 4 | Issue 6 | e5846Figure 3. QRT-PCR validation of differential gene expression. Age associated gene expression changes in MSC were validated by quantitative
RT-PCR. 10 genes were selected that have been differentially expressed in microarray data (A): regeneration associated muscle protease (RAMP);
maternally expressed 3 (MEG3); interleukin 13 receptor, alpha 2 (IL13RA2); S100 calcium binding protein A4 (S100A4) and triggering receptor
expressed on myeloid cells 1 (TREM1) were age-induced. Homeobox B3 (HOXB3) and Homeobox B7 (HOXB7); midline 1 (MID1); small nuclear RNA
Aging of Human Stem Cells
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The deterioration of the regenerative potential upon aging
might be due to functional changes in adult stem cells. To test this
hypothesis we have investigated differential gene expression in
primary, human MSC and HPC derived from different age
groups. In this study, we demonstrate for the first time age-related
gene expression changes in human MSC and HPC and that there
is a moderate but significant concordance in the expression profiles
upon aging in vivo and replicative senescence in vitro. It needs to be
pointed out, that chronological age and biological age do not
necessarily coincide. Multiparametric assessment of biological age
might be valuable in this context. Furthermore, MSC and HPC
preparations are heterogeneous and it is conceivable that they
represent a mixture of different aged or senescent subsets. Further
research will be necessary to address age-related changes on a
single cell level to investigate the heterogeneity of aging within cell
populations.
Figure 4. Age-induced gene expression of hematopoietic progenitor cells (HPC). CD34
+ HPC were isolated from cord blood (CB) or from
mobilized peripheral blood (PB) of healthy donors (27–73 years). Gene expression profiles revealed that 776 ESTs were significantly age-induced (red)
and 704 ESTs were age-repressed (green). We have combined the age-induced gene expression of HPC with replicative senescence data in MSC. The
heat map demonstrated here indicates an association between the two data sets.
doi:10.1371/journal.pone.0005846.g004
activating complex, polypeptide 5 (SNAPC5) and peroxisome proliferator-activated receptor gamma (PPARG) were age-repressed. Furthermore, we
have validated age associated changes in HPC for 9 genes (B): S100 calcium binding protein A10 (S100A10); vimentin (VIM); myeloid-associated
differentiation marker (MYADM); pim-1 oncogene (PIM1) and annexin A2 (ANXA2) were age-induced. Timeless interacting protein (TIPIN); myosin
regulatory light chain interacting protein (MYLIP); lymphocyte transmembrane adaptor 1 (LAX1) and Early growth response 1 (ERG1) were age-
repressed. Protocadherin 9 (PCDH9) was not amplified in HPC from elderly donors whereas interleukine 7 receptor (IL7R) was not amplified in young
samples (not presented in the figure). Differential gene expression was always calculated in relation to the mean of young samples. The mean fold-
ratio (6SD) is demonstrated for median aged and old donor samples. RT-PCR results (red) were always in line with microarray data (blue) for all genes
tested.
doi:10.1371/journal.pone.0005846.g003
Aging of Human Stem Cells
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regulated upon aging and most of these were age-repressed in
MSC (including HOXA5, HOXB3 and HOXB7). On the other
hand, several of these were age-induced in HPC (HOXA7,
HOXB5, HOXB6 and HOXB7). Thus, homeobox transcription
factors may not only function in morphogenesis and differentiation
but they might also be involved in the process of aging. Their
expression might be co-regulated for example by polycomb group
genes such as EZH2 [32]. It is remarkable that there was only little
overlap in age associated differential gene expression in MSC and
HPC. Furthermore, we did not detect any chromosomal locations
where age-induced gene expression changes are coherently over-
represented upon aging of MSC and HPC. It needs to be taken
into account that gene expression profiles reflect the effects of
aging rather than the initiating mechanism. Hence, it might not be
surprising that the molecular sequel of aging varies between
different cell types with different regulatory networks, different
environments and different cellular fates.
So far, only few studies have analyzed global gene expression
patterns in somatic stem cells upon aging and these were performed
in murine HPC [33–35]. Rossi and co-workers analyzed differential
expression ofHPC(c-kit
pos,li ne ag e
neg,Sc a- 1
pos,fl k2
2,C D 3 4
2)fr om
young (2–3 month) and old (22–24 month) mice by microarray [34].
Chambers etal. have also isolated HPC (c-kit
pos,l i n e a g e
neg,S c a - 1
pos)
from mice of different ages and analyzed differential gene expression
[33]. Overall there was only little overlap between these two studies,
Figure 5. Combination of the three datasets. Differential gene expression of the three datasets (MSC–donor age; HPC–donor age and MSC–
replicative senscence) was further compared. Venn diagrams demonstrate the overlap of differentially expressed ESTs that are up-regulated upon
aging (A) or down-regulated (B). Differentially expressed genes are indicated as short cut (Hugo name). There was only little overlap between MSC–
donor age and HPC–donor age. However, both datasets demonstrated a relatively high overlap with the dataset MSC–replicative senescence.
doi:10.1371/journal.pone.0005846.g005
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differencesbetween miceandmen aswellastodifferent cellfractions
used in these studies. However, with regard to Gene Ontology
categories there is some concordance between their and our results:
age-repressed genes were over-represented in categories involved in
genomic integrity, regulation of transcription and chromatin
remodeling [33,34]. Loss of these functions might underlie the
process of aging.
Fundamentally different ways have been proposed to explain
the process of aging: it might be evoked by stochastic or random,
accidental events that accumulate throughout life until the cell
looses its integrity or aging might be the result of a purposeful
program driven by regulated changes in gene expression or
epigenetic modifications [36]. The ‘‘disposable soma theory’’
suggests that the investments in durability and maintenance of
somatic tissues are conformed to life expectancy [37,38]. This
concept is compatible with our observation that genes involved in
genomic integrity and regulation of transcription are age-
repressed. There is experimental evidence that aging involves
DNA damage, accumulation of the cyclin-dependent kinase
Figure 6. Telomerase activity and 3D reconstruction of telomeres in HPC upon aging. TRAP assay was performed on CD34
+ cells of
different donor ages. HaCaT cells exhibiting a similar telomerase activity as HeLa cells were used as a positive control [75]. Telomerase activity in HPC
varied between hardly detectable and as high as in HaCaT cells with no clear association between the level of telomerase activity and donor age (A;
HaCaT cell lysat=positive control, HaCaT lysat + RNAse=negative control). Telomere length in HPC was estimated using 3D image reconstruction.
Cells were immunostained for CD34 (green), hybridized for telomeres with the telomere-specific PNA probe (red) and DNA counterstained with DAPI
(blue) (B). Graphic presentation of the telomere signal intensity measurement (arbitrary units) of CD34
+ cells from 19 different age donors
demonstrates a weak tendency of telomere shortening during age (C; the slope of linear regression is not significant, P=0.1034). The distribution of
telomere length in individual cells revealed a tendency for higher variation in telomere length in HPC of elderly donors (D; P=0.0450).
doi:10.1371/journal.pone.0005846.g006
Aging of Human Stem Cells
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their role in aging has been discussed [1,39–42]. Epigenetic
modifications such as DNA methylation or histone acetylation
might result in age associated molecular changes [33,43] and it is
conceivable that such epigenetic changes repress pathways
involved in genomic integrity, maintenance and repair.
The major question is whether replicative senescence does play
a role in human aging. Several studies have shown an inverse
relationship between donor age and the replicative life span in vitro
for fibroblasts or MSC [13,44,45]. This effect is usually relatively
small with a high variation between different donor samples
[12,46]. At least some of the variability was attributed to
differences in donor health status, conditions for the biopsy and
the initial CFU-F frequency in the bone marrow sample [47].
Furthermore, the pace of senescence might be affected by the
culture conditions [19,48]. In MSC preparations used in this study
we did not discern any age-associated effects on replicative
senescence. If the number of cumulative population doublings was
not significantly affected by aging it is all the more surprising, that
there was a significant association between age-induced gene
expression changes and replicative senescence. These results
indicate that the molecular sequels of aging in vivo and replicative
senescence in vitro are based on similar mechanisms.
Progressive shortening of the telomeres or modified telomeric
structures have been discussed to be the main trigger for
replicative senescence and it has been anticipated that telomere
shortening provides an internal clock. With every cell division the
number of telomere repeats decreases and this has also been
demonstrated for MSC [12,14]. The process is counteracted by
expression of telomerase in somatic stem cells [49,50]. This is in
line with our results where telomerase activity was detected in
HPC. Vaziri et al. have demonstrated that CD34
+CD38
2 HPC
from human bone marrow have shorter telomeres than those from
fetal liver or cord blood [51]. In this study telomere length
decreased only slightly upon aging and we did not detect
subpopulations with very short telomeres or signs of telomere
dysfunction (uncapped telomeres) in any of the samples. Hence, it
is unlikely that age-induced gene expression changes in HPC are
only due to telomere loss. Though discussed controversially, our
data rather support studies by others that telomere shortening may
not be the only reason for replicative senescence in hematopoietic
cells in vivo [40,52–54].
There is emerging evidence that aging is not purely a cell
intrinsic process, but rather regulated by interaction with the
cellular microenvironment. For example, Ju and co-workers have
demonstrated that telomere dysfunction induces alterations in the
microenvironment that affect aging of the hematopoietic system
[55]. In general, adult stem cells have a slow turnover and reside in
specialized niches, protected from the environment and only a few
are activated at a time [33,56]. By keeping adult stem cells in a
quiescent state, the stem cell niche might also play a crucial role in
regulating replicative senescence. Strong experimental data for this
hypothesis derives form serial transplantation experiments of HSC
in mice. The reconstituting ability declines continuously within 4
to 5 transfers [57,58] and this decline is thought to be telomere-
independent [59], although it has been reported that telomere
length decreases by serial transplantation [60]. Recently, Wilson
and co-workers have demonstrated that there is a dormant-
fraction of HSC that divides only five times during the lifetime of
mice and especially these dormant HSC posses repopulating
activity upon serial transplantation [61]. The stem cell niche could
therefore play a central role in maintaining a dormant pool of
HSC to prevent replicative senescence over the lifetime of the
organism [62].
In conclusion, the gene expression profiles indicate that our
stem and progenitor cells are not protected from aging. Further
research will be necessary to determine if aging also affects the
differentiation potential of stem cells. For example the myeloid
skewing of hematopoietic differentiation with age has been
suggested to be due to intrinsic changes in HSC [63,64]. If
replicative senescence is involved in aging, we should either be
running out of cell divisions or the increased time for cell division
or impairments of differentiation compromise regeneration of
organs, leading to their loss of function. Our data demonstrate that
gene expression changes upon in vivo aging and in vitro replicative
senescence are related.
Materials and Methods
Isolation of MSC from human bone marrow
MSC from human bone marrow were either isolated from bone
marrow aspirates from healthy donors for allogeneic transplanta-
tion (BM) or from the caput femoris from elderly patients
undergoing femoral head prosthesis (HIP) [65]. All samples were
taken after written consent using guidelines approved by the Ethic
Committee on the Use of Human Subjects at the University of
Heidelberg. 20 ml bone marrow aspirate with heparin were taken
from healthy donors for allogeneic bone marrow transplantation
and immediately processed by ficoll density fractionation for
isolation of mononuclear cells (MNC). Alternatively, the femur
head was flushed with PBS under sterile conditions immediately
after operation and subsequently the MNC were isolated by ficoll
density fractionation. All samples were cultured under the same
standardized culture conditions as described before [16,66–68].
Tissue culture flasks were coated with 10 ng/ml fibronectin
(Sigma) before use.
Expansion and sampling of MSC
MSC were cultured at 37uC in a humidified atmosphere
containing 5% carbon dioxide with medium changes twice a week.
After 7–10 days, initial colonies were trypsinized and re-plated in a
new culture flask (passage 1, P1). Upon sub-confluent growth
(70%), cells were re-plated at a density of 10
4 cells/cm
2. Photo
documentation and cell counting by using a Neubauer counting
chamber was performed at every passage. Cumulative population
doublings were calculated as previously described [46]. As cell
numbers were first determined at P1, the cumulative doubling
number was first calculated for P2. From P2 onward, there were
enough cells for simultaneous expansion of one fraction and
harvesting another fraction for subsequent analyses: 10
6 cells were
lysed in TRIzol and stored at 280uC for RNA isolation and 10
6
cells were cryopreserved for immunophenotyping and in vitro
differentiation.
Immunophenotypic analysis and in vitro differentiation
of MSC
Immunophenotypic characterization of MSC preparations was
performed on a three-color FACScan (Becton Dickinson [BD],
San Jose, USA) with a five-color upgrade (Cytek Dev. Inc.,
Fremont, Ca, USA) using the commonly used panel of antibodies
as described before [16,66]: CD13-allophycocyanin (APC, clone
WM15, BD), CD29-fluorescein isothiocyanate (FITC, MEM-
101a, abcam, Cambridge, UK), CD31-FITC (BD), CD34-
phycoerythrin (PE, 8G12, BD), CD44-PE (g44-26, BD), CD45-
FITC (2D1, BD), CD73-PE (AD2, BD), CD90-PE (G7, BD),
CD105-PE (MHCD10504, BD), CD146-PE (P1H12, BD),
CD166-PE (3A6, BD), CD184-PE (12G5, BD). To induce
osteogenic differentiation, cells were re-plated at 2610
4 cells/
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2 and cultured for three weeks in DMEM with 10% FCS
(Invitrogen), 10 mM b-glycerophosphate, 10
27 M dexametha-
sone, and 0.2 mM ascorbic acid and with medium changes every 3
to 4 days as previously described [68,69]. After 21 days, cells were
analyzed by Alizarin red staining. For adipogenic differentiation,
cells were plated at 2610
4 cells/cm
2 and cultured in DMEM with
10% FCS, 0.5 mM isobutyl-methylxanthine (IBMX), 1 mM
dexamethasone, 10 mM insulin, 200 mM indomethacin, and Oil
Red-O staining was performed after 21 days [70].
Senescence associated beta-galactosidase staining
Expression of pH-dependent senescence associated beta-galac-
tosidase (SA-beta-gal) activity was analyzed simultaneously in
different passages of MSC of young and old donors using the SA-
beta-gal staining kit (Cell Signaling Technology, Boston, MA).
Isolation and sampling of human HPC
Human HPC were isolated within the CD34
+ cell fraction of
fresh umbilical cord blood (CB). Alternatively they were isolated
form peripheral blood (PB) of healthy donors upon mobilization
with granulocyte-colony stimulating factor (G-CSF) before leuka-
pheresis procedure for allogeneic stem cell transplantation. All
samples were taken after written consent using guidelines
approved by the Ethic Committee on the Use of Human Subjects
at the University of Heidelberg. Mononuclear cells were isolated
after centrifugation on Ficoll-hypaque (Biochrom KG, Berlin,
Germany). CD34
+ cells were enriched using a monoclonal anti-
CD34 antibody labeled with magnetic beads on an autoMACS
system (Miltenyi Biotec, Bergisch-Gladbach, Germany). After
additional staining with anti-CD34-APC (BD) further purification
was achieved using the FACS-Vantage-SE flow cytometry cell
sorter. Staining with propidium iodide (PI) was performed to allow
exclusion of non-viable cells. Reanalysis revealed purity higher
than 95%. 10
5 cells were lysed in TRIzol and stored at 280uC for
RNA isolation. From the same population cells were lysed in
CHAPS buffer for TRAP assay and were transferred (cytospin
centrifugation) to glass slides for telomere length analysis,
respectively.
RNA isolation
Total RNA was isolated using TRIzol reagent (Invitrogen,
Paisley, Scotland) according to the manufacturer’s instructions.
RNA quality was controlled using the RNA 6000 Pico LabChip kit
(Agilent, Waldbronn, Germany) and quantified with a NanoDrop
ND-1000 Spectrophotometer (Nanodrop Technologies, Wilming-
ton, USA).
Microarray experiments
In this study we have compared three different sets of
microarray data:
1) MSC-donor age: MSC samples were taken from 4 young donors
(21–25 years), 4 median aged donors (44–55 years) and 4 old
donors (80–92 years). For this comparison MSC were
harvested after the second passage (P2). Two mg of total
RNA were amplified with GeneChip one-cycle target labeling
kit (Affymetrix, High Wycombe, United Kingdom) according
to the manufacturer’s instructions. Quality of amplified RNA
was controlled by LabChip technology. GeneChip Human
Genome U133_Plus_2.0 (Affymetrix) were hybridized with
15 mg amplified RNA, washed with a fluidics station 450
(Affymetrix), and scanned with GeneChip scanner 3000
(Affymetrix). The complete microarray data and MIAME
compliant information have been deposited in NCBIs Gene
Expression Omnibus (GEO, http://www.ncbi.nlm.nih.gov/
geo/) and are accessible through GEO Series accession
number GSE12274.
2) MSC-replicative senescence: for a direct comparison with age-
induced gene expression changes we have reanalyzed our
recently published data on replicative senescence in MSC as
described below [16]. Here, we have only considered the 9
hybridizations of the different passages of a 44 year old donor
(donor 1; passages 2, 3, 4, 5, 6, 7, 8, 10 and 11; passage 9
could repeatedly not be amplified). Two mg of total RNA
were amplified, quality controlled and hybridized to the
U133_Plus_2.0 Affymetrix chip as described above. The
complete microarray data are accessible through GEO Series
accession number GSE9593.
3) HPC-donor age: CD34
+ cells were isolated from 4 cord blood
samples and from 15 samples of mobilized peripheral blood
from donors ranging from 27 to 73 years. 100 ng of total
RNA were amplified with the two-cycle target labeling kit
(Affymetrix) and 10 mg amplified RNA were hybridized on
the GeneChip Human Genome U133_Plus_2.0 platform
(Affymetrix). The complete microarray data is accessible
through GEO series accession number GSE12277.
Analysis of microarray data
The three datasets (MSC-donor age; MSC-replicative senescence and
HPC-donor age) were independently normalized and analyzed using
the same methods: Raw data were quantil normalized [71]. The
signal intensities for each gene were then median-normalized and
log2 transformed. For subsequent analysis we have only
considered probe sets that were detected as present in more than
50% of the hybridisations of each data set. To identify differential
gene expression that correlated with increasing age (or passage) we
have performed Pavlidis template matching (PTM) using the
MultiExperiment Viewer (MeV, TM4) [72]. The template was
specified according to the increasing age (or passage) of the
different samples. This method ranks genes by statistical score,
permitting further analysis to focus on the most significant without
the need of discriminatory classification according to age groups
[73]. The threshold criterion for matching can be either the
magnitude of the correlation coefficient (R), or the significance (P-
value) of the correlation coefficient. Genes that were either up-
regulated or down-regulated with a P-value ,0.01 were further
classified by GeneOntology analysis using GoMiner software
(http://discover.nci.nih.gov/gominer/) and representation in
functional categories was analyzed by Fischer’s Exact p-value test.
Chromosomal distribution of differentially regulated genes was
analyzed by Chromosomal Co-Localization probability calculator
(ChroCoLoc) [74].
Quantitative real-time PCR analysis
Quantification of mRNA expression for candidate genes was
performed by real-time quantitative PCR (QRT-PCR) using the
ABI PRISMH 7700HT Sequence Detection System Instrument
(Applied Biosystems, Applera Deutschland GmbH, Darmstadt,
Germany). Total RNA was reverse transcribed by using the high
capacity cDNA reverse transcription kit (Applied Biosystems).
Primers were obtained from Biospring (Frankfurt, Germany) (table
S5). QRT-PCR reactions were performed with the power SYBRH
green PCR master mix in a MicroAmp optical 96-well reaction
plate with a ABI PRISMH 7700HT sequence detector (Applied
Biosystems) according to the manufacturer’s instructions. Gene
expression levels were normalized to GAPDH expression, which
was used as a housekeeping gene.
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Cell lysis of CD34-positive cells and HaCaT cells [75] and
telomerase assay were performed using the TRAPeze kit (Intergen
Company, Oxford, UK, now sold by Q-Biogene, Heidelberg,
Germany) as described previously [31].
3D telomeric quantitative Fluorescence in situ
hybridization (3D-Telo-Q-FISH) analysis
HPC of different donor age were cytospinned to slides, fixed for
10 min in 3.7% formaldehyde buffered with PBS, washed with
PBS for 15 min, rinsed in ddH2O and air-dried. Cells were labeled
with anti-CD34 (Cymbus Biotechnology LTD) detected by a
secondary Alexa488-conjugated anti-mouse antibody (Invitrogen).
Fixation, washing and air drying were repeated to stabilize the
primary-secondary antibody complex. Thereafter, telomere stain-
ing was accomplished with a Cy3-labeled PNA probe (PNA
Telomere FISH Kit K5326). Hybridisation, image acquisition,
signal quantification and recalculation of arbitary units to telomere
length in kb was performed as described previously [30].
Supporting Information
Figure S1 Immunophenotype of MSC. Representative flow
cytometry histograms of MSC from human bone marrow are
presented (CD13+, CD29+, CD312, CD342, CD44+, CD452,
CD73+, CD90+, CD105+, CD146+/2, CD166+, CD1842).
There were no age-associated differences in the immunopheno-
type of MSC from young or elderly donors.
Found at: doi:10.1371/journal.pone.0005846.s001 (1.65 MB TIF)
Figure S2 In vitro differentiation of MSC. MSC of young and
elderly donors were simultaneously differentiated along adipogenic
or osteogenic line. Fat accumulation was visualized by Oil Red-O
staining. Osteogenic differentiation was visualized by Alizarin red
staining. There were no age-associated differences in the
differentiation potential of MSC. (scale bar=100 mm)
Found at: doi:10.1371/journal.pone.0005846.s002 (5.28 MB TIF)
Figure S3 beta-galactosidase staining of MSC. Senescence
associated beta-galactosidase staining increases in the later
passages of MSC (scale bar=100 mm).
Found at: doi:10.1371/journal.pone.0005846.s003 (7.44 MB TIF)
Figure S4 RT-PCR analysis of independent donor samples. Age
associated gene expression changes in MSC were validated in
independent donor samples of young (26 and 30 years old),
median (35 and 45 years) and elderly donors (76 and 85 years old).
Differential expression was analyzed by RT-PCR (A). Further-
more, we have isolated HPC from two additional cord bloods,
three young (20, 26, 26 years old) and three elderly donors (49, 55,
58 years old) (B). Differential gene expression was always
calculated in relation to the mean of young samples. The mean
fold-ratio (6SD) is demonstrated. RT-PCR results (red) validated
age associated gene expression changes as observed in microarray
data (blue).
Found at: doi:10.1371/journal.pone.0005846.s004 (1.47 MB TIF)
Figure S5 Gene expression changes in MSC upon serial
passaging. Differential gene expression of different passages of
the same MSC preparation (44 years old) was analyzed by
Affymetrix GeneChip technology as described before [16]. This
data was now reanalysed by different statistical methods for direct
comparison of datasets. Analysis by Pavlidis template matching
revealed that 1257 expressed sequence tags (ESTs) were
significantly up-regulated (red; P,0.01) and 698 ESTs were
down-regulated (green) upon replicative senescence.
Found at: doi:10.1371/journal.pone.0005846.s005 (3.78 MB TIF)
Figure S6 Cell numbers in mobilized peripheral blood. The
number of MNC per ml blood (A), of CD34+ cells (B) and the
percentage of CD34+ HPC in MNC (C) was determined for cord
blood samples and for the mobilized peripheral blood samples.
There was no correlation between donor age and the number of
HPC in the blood.
Found at: doi:10.1371/journal.pone.0005846.s006 (0.57 MB TIF)
Figure S7 Functional categories of differentially expressed
genes. GeneOnthology analysis was performed for the subsets of
genes that were significantly up-regulated (red) or down-regulated
(green) in MSC-donor age (A), HPC-donor age (B) and MSC-
replicative senescence (C). The number of non-redundant genes in
each category was compared to all genes (grey) on the microarray.
The 10 most significant categories are depicted and the
percentages of genes that contributed to representative categories
are presented (P,0.0001).
Found at: doi:10.1371/journal.pone.0005846.s007 (5.09 MB TIF)
Figure S8 Serial dilution for the TRAP assay. All cell lysates
were diluted with extract from telomerase-negative fibroblasts in
order to maintain comparable protein concentrations in the
extract. All lysates show a dilution-dependent reduction in
telomerase activity, demonstrating that reduced activity in some
samples was not due to the presence of inhibitors. H+=HaCaT
lysate with RNase, LB=lysis buffer control, IC=internal 34 bp
standard
Found at: doi:10.1371/journal.pone.0005846.s008 (5.02 MB TIF)
Table S1 Gene list of differentially expressed genes in aging of
MSC. This table summarizes significantly age-induced (red; 99
ESTs) and age-repressed genes (green; 85 ESTs). The table
contains the following columns: 1) Affymetrix ID, 2) Gene Titel, 3)
Gene Symbol, 4) Chromosomal location, 5) number of present
detections in 12 hybridizations, 6) Correlation coefficient with the
template (PTM-matching), and 7) P-value.
Found at: doi:10.1371/journal.pone.0005846.s009 (0.06 MB
XLS)
Table S2 Gene list of differentially expressed genes in replicative
senescence of MSC. This table summarizes significantly senes-
cence-induced (red; 1257 ESTs) and senescence-repressed genes
(green; 698 ESTs). The table contains the following columns: 1)
Affymetrix ID, 2) Gene Titel, 3) Gene Symbol, 4) Chromosomal
location, 5) number of present detections in 9 hybridizations, 6)
Correlation coefficient with the template (PTM-matching), and 7)
P-value.
Found at: doi:10.1371/journal.pone.0005846.s010 (0.40 MB
XLS)
Table S3 Gene list of differentially expressed genes in aging of
HPC. This table summarizes significantly age-induced (red; 776
ESTs) and age-repressed genes (green; 704 ESTs). The table
contains the following columns: 1) Affymetrix ID, 2) Gene Titel, 3)
Gene Symbol, 4) Chromosomal location, 5) number of present
detections in 19 hybridizations, 6) Correlation coefficient with the
template (PTM-matching), and 7) P-value.
Found at: doi:10.1371/journal.pone.0005846.s011 (0.31 MB
XLS)
Table S4 Differentially expressed genes are over-represented in
chromosomal bands.
Found at: doi:10.1371/journal.pone.0005846.s012 (0.02 MB
XLS)
Table S5 Primer list.
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XLS)
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